Archive
FTSE 100 closes lower as traders mull Fed testimony
The UK's premier share index finished down over five points lower at 7,530,
Company
ValiRx PLC
LON:VAL
ValiRx is a drug development company, which focuses on the translation of scientific innovation into clinical candidates for cancer, related conditions and women’s health. The company's specialised business model connects science, finance and commerce to accelerate early-stage drug development. It identifies proprietary and novel drug candidates with the potential to improve patient lives, providing the expertise and investment required for optimised development and value creation.
310 stories · page 2 of 16
Archive
Proactive news snapshot: Argo Blockchain, ValiRx, Arc Minerals, Directa Plus ...
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Distil down the plug-hole after slump in revenues
A look at the day's major movers, including C&C, Global Ports, Carclo, ValiRx, IGas, Intelligent Ultrasound, Richland Resources and Bango
ValiRx readying itself for VAL301 clinical trials
ValiRx has brought in a contract research organisation that will help it take VAL301 into the clinic
Investments and investor services
FTSE 100 closes a shade lower as markets uninspired; US celebrates Independence Day holiday
The Footsie finished down nearly six points at 7,603
Archive
Proactive news snapshot: 88 Energy, Tekcapital, AFC Energy, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
Kibo Energy the day's top riser as its moves to secure total ownership of the Bordersley project
A look at the day's major movers, including 88 Energy, Two Shields, Inland Homes, Avingtrans, Creightons, RM2 and RPS Group
ValiRx secures US patent for VAL201 cancer drug
ValiRx had already been granted worldwide rights for the use of VAL201 in prostate cancer, and US officials have now allowed claims for the use of the drug in the prevention and treatment of metastatic cancer, including prostate cancer
Archive
FTSE 100 still stuck in neutral; G20 meeting can't come soon enough
Bitcoin is up more than 10% but the shine has come off gold a bit
ValiRx agrees break fee as it terminates financing agreement
ValiRx will pay a break fee of £212,500 to European High Growth Opportunities SF after the pair agreed to terminate the financing deal
Archive
Proactive news snapshot: Shanta Gold, Ceres Power, Anglo Asian Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
BCA Marketplace board minded to recommend 243p a share offer, if it is made
A look at the day's major movers, including Premier Technical, Evraz, Gunsynd, Dixons Carphone, Serabi Gold and EVR
ValiRx shares jump as firm cleared to increase clinical trial dosing
Investors were also told data from the trial is currently being collated for examination by independent experts, with Dr Mark Linch appointed as principal investigator
Investments and investor services
FTSE 100 closes higher as global markets buoyed by Fed's hint on rates
Carnival and Evra were the two big fallers among Footsie constituents
Investments and investor services
Maistro shares to become just a blurred memory
A look at the day's major movers, including Great Western Mining, Majestic Wine, Ascent, Ferguson and Just Group
Archive
Proactive news snapshot: Tekcapital, Quadrise Fuels International, Sareum Holdings …
A glance at some of the day's highlights from the Proactive Investors newswire
ValiRX raises funds to meet immediate working capital needs and develop drugs
ValiRX expects to pay European High Growth Opportunities Securitisation Fund up to £150,000 to terminate a subscription agreement.
Archive
Scapa boss not scarpering after all
A look at the day's major movers, including Helical, Ocado, Thomas Cook, Scapa, Dods Group, Rockfire Resources and Avesoro Resources
Archive
Proactive news snapshot: AfriTin Mining, Union Jack Oil, Eurasia Mining …
A glance at some of the day's highlights from the Proactive Investors newswire